GlassScriptPhysician profile
Dionne Bell
NPI 1588006431
$24,152.53
in general payments reported to CMS, 2019-2025
13 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $491 · 2022: $330 · 2023: $475 · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $4,787 · Food and Beverage: $3,021 · Education: $28.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,495.00 |
| Travel and Lodging | $4,787.09 |
| Food and Beverage | $3,021.33 |
| Education | $28.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $22,601.22 | 2022-2025 | Biktarvy, Yeztugo |
| Viiv Healthcare Company | $527.84 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $235.12 | 2021-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $213.30 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Products, LP | $198.00 | 2021-2022 | |
| Napo Pharmaceuticals INC | $119.61 | 2021-2024 | Mytesi |
| Theratechnologies INC. | $83.77 | 2021 | |
| Dexcom, INC. | $60.57 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $36.61 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $28.48 | 2023 | |
| Glaxosmithkline, LLC. | $22.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.27 | 2025 | |
| Lilly USA, LLC | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dionne Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.